{"id":"https://openalex.org/W1995200019","doi":"https://doi.org/10.1371/journal.pone.0107255","title":"Cost-Effectiveness of Treatment Strategies for BRAF-Mutated Metastatic Melanoma","display_name":"Cost-Effectiveness of Treatment Strategies for BRAF-Mutated Metastatic Melanoma","publication_year":2014,"publication_date":"2014-09-08","ids":{"openalex":"https://openalex.org/W1995200019","doi":"https://doi.org/10.1371/journal.pone.0107255","mag":"1995200019","pmid":"https://pubmed.ncbi.nlm.nih.gov/25198196","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/4157865"},"language":"en","primary_location":{"id":"doi:10.1371/journal.pone.0107255","doi":"https://doi.org/10.1371/journal.pone.0107255","is_oa":true,"landing_page_url":"https://doi.org/10.1371/journal.pone.0107255","pdf_url":"https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0107255&type=printable","source":{"id":"https://openalex.org/S202381698","display_name":"PLoS ONE","issn_l":"1932-6203","issn":["1932-6203"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","doaj","dongbi-c","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315706","host_organization_name":"Public Library of Science","host_organization_lineage":["https://openalex.org/P4310315706"],"host_organization_lineage_names":["Public Library of Science"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"PLoS ONE","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0107255&type=printable","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5085131149","display_name":"Patti K. Curl","orcid":"https://orcid.org/0000-0003-2295-2670","observed_orcids":["https://orcid.org/0000-0003-2295-2670"]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Patti Curl","raw_affiliation_strings":["University of California San Francisco, San Francisco, California, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of California San Francisco, San Francisco, California, United States of America","institution_ids":["https://openalex.org/I180670191"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083160716","display_name":"Igor Vujic","orcid":"https://orcid.org/0000-0003-3013-9823","observed_orcids":["https://orcid.org/0000-0003-3013-9823"]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]},{"id":"https://openalex.org/I4210111069","display_name":"Krankenanstalt Rudolfstiftung der Stadt Wien","ror":"https://ror.org/019myg640","country_code":"AT","type":"healthcare","lineage":["https://openalex.org/I4210111069","https://openalex.org/I4210117134"]}],"countries":["AT","US"],"is_corresponding":false,"raw_author_name":"Igor Vujic","raw_affiliation_strings":["University of California San Francisco, San Francisco, California, United States of America; The Rudolfstiftung Hospital, Vienna, Austria","The Rudolfstiftung Hospital, Vienna, Austria","University of California San Francisco, San Francisco, California, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of California San Francisco, San Francisco, California, United States of America; The Rudolfstiftung Hospital, Vienna, Austria","institution_ids":["https://openalex.org/I180670191"]},{"raw_affiliation_string":"The Rudolfstiftung Hospital, Vienna, Austria","institution_ids":["https://openalex.org/I4210111069"]},{"raw_affiliation_string":"University of California San Francisco, San Francisco, California, United States of America","institution_ids":["https://openalex.org/I180670191"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014135109","display_name":"Laura van \u2018t Veer","orcid":"https://orcid.org/0000-0002-9838-8298","observed_orcids":["https://orcid.org/0000-0002-9838-8298"]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]},{"id":"https://openalex.org/I4210167126","display_name":"UCSF Helen Diller Family Comprehensive Cancer Center","ror":"https://ror.org/05yndxy10","country_code":"US","type":"facility","lineage":["https://openalex.org/I180670191","https://openalex.org/I4210110664","https://openalex.org/I4210167126"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Laura J. van \u2018t Veer","raw_affiliation_strings":["UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California, United States of America","institution_ids":["https://openalex.org/I180670191","https://openalex.org/I4210167126"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028258636","display_name":"Susana Ortiz\u2010Urda","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]},{"id":"https://openalex.org/I4210167126","display_name":"UCSF Helen Diller Family Comprehensive Cancer Center","ror":"https://ror.org/05yndxy10","country_code":"US","type":"facility","lineage":["https://openalex.org/I180670191","https://openalex.org/I4210110664","https://openalex.org/I4210167126"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Susana Ortiz-Urda","raw_affiliation_strings":["UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California, United States of America","institution_ids":["https://openalex.org/I180670191","https://openalex.org/I4210167126"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5052308665","display_name":"James G. Kahn","orcid":"https://orcid.org/0000-0002-1259-7233","observed_orcids":["https://orcid.org/0000-0002-1259-7233"]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"James G. Kahn","raw_affiliation_strings":["University of California San Francisco, San Francisco, California, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of California San Francisco, San Francisco, California, United States of America","institution_ids":["https://openalex.org/I180670191"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5085131149"],"corresponding_institution_ids":["https://openalex.org/I180670191"],"apc_list":{"value":2382,"currency":"USD","value_usd":2382},"apc_paid":{"value":2382,"currency":"USD","value_usd":2382},"fwci":11.5712,"has_fulltext":true,"cited_by_count":43,"citation_normalized_percentile":{"value":0.97978418,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":90,"max":99},"biblio":{"volume":"9","issue":"9","first_page":"e107255","last_page":"e107255"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.9872999787330627,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},"topics":[{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.9872999787330627,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T12708","display_name":"Economic and Financial Impacts of Cancer","score":0.004100000020116568,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T11533","display_name":"Melanoma and MAPK Pathways","score":0.0038999998942017555,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/vemurafenib","display_name":"vemurafenib","score":0.9869999885559082},{"id":"https://openalex.org/keywords/ipilimumab","display_name":"ipilimumab","score":0.9959999918937683},{"id":"https://openalex.org/keywords/dacarbazine","display_name":"dacarbazine","score":0.9789999723434448},{"id":"https://openalex.org/keywords/cost-effectiveness","display_name":"cost-effectiveness","score":0.8560000061988831},{"id":"https://openalex.org/keywords/quality-adjusted-life-years","display_name":"quality-adjusted life years","score":0.8159999847412109},{"id":"https://openalex.org/keywords/targeted-cancer-therapy","display_name":"targeted cancer therapy","score":0.75},{"id":"https://openalex.org/keywords/drug-costs","display_name":"drug costs","score":0.7770000100135803},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.6240000128746033},{"id":"https://openalex.org/keywords/immunotherapy","display_name":"immunotherapy","score":0.47099998593330383},{"id":"https://openalex.org/keywords/decision-tree","display_name":"decision tree","score":0.5170000195503235}],"concepts":[{"id":"https://openalex.org/C2776131300","wikidata":"https://www.wikidata.org/wiki/Q423111","display_name":"Vemurafenib","level":4,"score":0.9731569290161133},{"id":"https://openalex.org/C2780964509","wikidata":"https://www.wikidata.org/wiki/Q416975","display_name":"Dacarbazine","level":3,"score":0.8710803985595703},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8456444144248962},{"id":"https://openalex.org/C2781433595","wikidata":"https://www.wikidata.org/wiki/Q2459042","display_name":"Ipilimumab","level":4,"score":0.8326398134231567},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5641739964485168},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5382919311523438},{"id":"https://openalex.org/C2777658100","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Melanoma","level":2,"score":0.5371042490005493},{"id":"https://openalex.org/C2994587330","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Metastatic melanoma","level":3,"score":0.34517359733581543},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.2663680911064148},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.18404501676559448},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.1702961027622223},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.12917551398277283}],"mesh":[{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":true},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D003362","descriptor_name":"Cost-Benefit Analysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008545","descriptor_name":"Melanoma","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":false},{"descriptor_ui":"D008545","descriptor_name":"Melanoma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D008545","descriptor_name":"Melanoma","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D008545","descriptor_name":"Melanoma","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D009154","descriptor_name":"Mutation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D009362","descriptor_name":"Neoplasm Metastasis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011379","descriptor_name":"Prognosis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011788","descriptor_name":"Quality of Life","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015233","descriptor_name":"Models, Statistical","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D048493","descriptor_name":"Proto-Oncogene Proteins B-raf","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true}],"locations_count":8,"locations":[{"id":"doi:10.1371/journal.pone.0107255","doi":"https://doi.org/10.1371/journal.pone.0107255","is_oa":true,"landing_page_url":"https://doi.org/10.1371/journal.pone.0107255","pdf_url":"https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0107255&type=printable","source":{"id":"https://openalex.org/S202381698","display_name":"PLoS ONE","issn_l":"1932-6203","issn":["1932-6203"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","doaj","dongbi-c","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315706","host_organization_name":"Public Library of Science","host_organization_lineage":["https://openalex.org/P4310315706"],"host_organization_lineage_names":["Public Library of Science"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"PLoS ONE","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:4157865","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/4157865","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"PLoS One","raw_type":"Text"},{"id":"pmid:25198196","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/25198196","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"PloS one","raw_type":"Journal Article"},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.795.5329","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.795.5329","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"ftp://ftp.ncbi.nlm.nih.gov/pub/pmc/d6/94/pone.0107255.PMC4157865.pdf","raw_type":"text"},{"id":"pmh:oai:RePEc:plo:pone00:0107255","doi":null,"is_oa":false,"landing_page_url":"https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0107255","pdf_url":null,"source":{"id":"https://openalex.org/S4306401271","display_name":"RePEc: Research Papers in Economics","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I77793887","host_organization_name":"Federal Reserve Bank of St. Louis","host_organization_lineage":["https://openalex.org/I77793887"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"article"},{"id":"pmh:oai:doaj.org/article:07f9d429ffdf416597d3b5d0f9adbfd8","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/07f9d429ffdf416597d3b5d0f9adbfd8","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"PLoS ONE, Vol 9, Iss 9, p e107255 (2014)","raw_type":"article"},{"id":"pmh:oai:escholarship.org/ark:/13030/qt8vk0572t","doi":null,"is_oa":false,"landing_page_url":"https://escholarship.org/uc/item/8vk0572t","pdf_url":null,"source":{"id":"https://openalex.org/S4306400115","display_name":"eScholarship (California Digital Library)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I2801248553","host_organization_name":"California Digital Library","host_organization_lineage":["https://openalex.org/I2801248553"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"article"},{"id":"pmh:qt8vk0572t","doi":null,"is_oa":false,"landing_page_url":"http://www.escholarship.org/uc/item/8vk0572t","pdf_url":null,"source":{"id":"https://openalex.org/S4306400115","display_name":"eScholarship (California Digital Library)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I2801248553","host_organization_name":"California Digital Library","host_organization_lineage":["https://openalex.org/I2801248553"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Kahn, James; Van 'T Veer, Laura; Curl, P; Vujic, I; Van, LJ; Ortiz-Urda, S; \u00c2\u00a0et al.(2014). Cost-effectiveness of treatment strategies for BRAF-mutated metastatic melanoma. UC San Francisco: Retrieved from: http://www.escholarship.org/uc/item/8vk0572t","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1371/journal.pone.0107255","doi":"https://doi.org/10.1371/journal.pone.0107255","is_oa":true,"landing_page_url":"https://doi.org/10.1371/journal.pone.0107255","pdf_url":"https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0107255&type=printable","source":{"id":"https://openalex.org/S202381698","display_name":"PLoS ONE","issn_l":"1932-6203","issn":["1932-6203"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","doaj","dongbi-c","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315706","host_organization_name":"Public Library of Science","host_organization_lineage":["https://openalex.org/P4310315706"],"host_organization_lineage_names":["Public Library of Science"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"PLoS ONE","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9476000070571899,"id":"https://metadata.un.org/sdg/3"}],"sustainable_development_goals_aurora":[],"study_designs":[],"awards":[{"id":"https://openalex.org/G1144540498","display_name":"Role of KIT in Early Melanoma Development","funder_award_id":"K08CA155035","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G9000895751","display_name":"Center for AIDS Prevention Studies (CAPS)","funder_award_id":"P30MH062246","funder_id":"https://openalex.org/F4320337346","funder_display_name":"National Institute of Mental Health"}],"funders":[{"id":"https://openalex.org/F4320337346","display_name":"National Institute of Mental Health","ror":"https://ror.org/04xeg9z08"},{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W1995200019.pdf","grobid_xml":"https://content.openalex.org/works/W1995200019.grobid-xml"},"referenced_works_count":20,"referenced_works":["https://openalex.org/W1813879195","https://openalex.org/W1879616740","https://openalex.org/W1917632054","https://openalex.org/W1992331783","https://openalex.org/W1998551984","https://openalex.org/W2002501169","https://openalex.org/W2032397328","https://openalex.org/W2043951092","https://openalex.org/W2055727380","https://openalex.org/W2086891934","https://openalex.org/W2097995306","https://openalex.org/W2114847324","https://openalex.org/W2123363005","https://openalex.org/W2128542677","https://openalex.org/W2134047636","https://openalex.org/W2136474966","https://openalex.org/W2156078931","https://openalex.org/W2166262263","https://openalex.org/W2168143310","https://openalex.org/W2787145482"],"related_works":["https://openalex.org/W1567636964","https://openalex.org/W2007052849","https://openalex.org/W7095459821","https://openalex.org/W2553114403","https://openalex.org/W4317209810","https://openalex.org/W2412269814","https://openalex.org/W2106244677","https://openalex.org/W2949049949","https://openalex.org/W4366546212","https://openalex.org/W2005659934"],"abstract_inverted_index":{"PURPOSE:":[0],"Genetically-targeted":[1],"therapies":[2],"are":[3,33,64],"both":[4],"promising":[5],"and":[6,121],"costly":[7],"advances":[8],"in":[9,22,47,221],"the":[10,23,37,44,84,115,138,141,180,185],"field":[11],"of":[12,40,75,118,201,213,239],"oncology.":[13],"Several":[14],"treatments":[15],"for":[16,55,100,126,146,163,187,211,226],"metastatic":[17,104,215],"melanoma":[18,105,216],"with":[19,58,102,149,169,197,217,233],"a":[20,56,78,93,107,198,240],"mutation":[21],"BRAF":[24],"gene":[25],"have":[26],"been":[27],"approved.":[28],"They":[29],"extend":[30],"life":[31,123],"but":[32],"more":[34],"expensive":[35],"than":[36],"previous":[38],"standard":[39],"care":[41],"(dacarbazine).":[42],"Vemurafenib,":[43],"first":[45],"drug":[46,235],"this":[48],"class,":[49],"costs":[50,120],"$13,000":[51],"per":[52,72,153,194,203,208],"month":[53],"($207,000":[54],"patient":[57],"median":[59],"survival).":[60],"Patients":[61],"failing":[62],"vemurafenib":[63,147,164,170,188,218],"often":[65],"given":[66],"ipilimumab,":[67],"an":[68],"immunomodulator,":[69],"at":[70],"$150,000":[71],"course.":[73],"Assessment":[74],"cost-effectiveness":[76,143],"is":[77],"valuable":[79],"tool":[80],"to":[81,96,113,192],"help":[82],"navigate":[83],"transition":[85],"toward":[86],"targeted":[87],"cancer":[88],"therapy.":[89],"METHODS:":[90],"We":[91,129],"performed":[92,130],"cost-utility":[94],"analysis":[95],"compare":[97],"three":[98],"strategies":[99,229],"patients":[101],"BRAF+":[103,214],"using":[106],"deterministic":[108],"expected-value":[109],"decision":[110],"tree":[111],"model":[112],"calculate":[114],"present":[116],"value":[117],"lifetime":[119],"quality-adjusted":[122],"years":[124],"(QALYs)":[125],"each":[127],"strategy.":[128],"sensitivity":[131,175],"analyses":[132],"on":[133,183],"all":[134],"variables.":[135],"RESULTS:":[136],"In":[137,174],"base":[139],"case,":[140],"incremental":[142],"ratio":[144],"(ICER)":[145],"compared":[148,168],"dacarbazine":[150,190],"was":[151,172],"$353,993":[152],"QALY":[154,195,209],"gained":[155,196,210],"(0.42":[156],"QALYs":[157],"added,":[158],"$156,831":[159],"added).":[160],"The":[161,206],"ICER":[162,186],"followed":[165],"by":[166],"ipilimumab":[167],"alone":[171,219],"$158,139.":[173],"analysis,":[176],"treatment":[177,199,212],"cost":[178,200,207],"had":[179],"largest":[181],"influence":[182],"results:":[184],"versus":[189],"dropped":[191],"$100,000":[193],"$3600":[202],"month.":[204],"CONCLUSION:":[205],"or":[220,237],"combination":[222],"exceeds":[223],"widely-cited":[224],"thresholds":[225],"cost-effectiveness.":[227],"These":[228],"may":[230],"become":[231],"cost-effective":[232],"lower":[234],"prices":[236],"confirmation":[238],"durable":[241],"response":[242],"without":[243],"continued":[244],"treatment.":[245]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":7},{"year":2018,"cited_by_count":7},{"year":2017,"cited_by_count":4},{"year":2016,"cited_by_count":4},{"year":2015,"cited_by_count":6}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}